scispace - formally typeset
Y

Yashdeep Gupta

Researcher at All India Institute of Medical Sciences

Publications -  229
Citations -  2534

Yashdeep Gupta is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Diabetes mellitus & Gestational diabetes. The author has an hindex of 23, co-authored 201 publications receiving 1896 citations. Previous affiliations of Yashdeep Gupta include M.G.M. Medical College & Mahatma Gandhi Memorial Medical College.

Papers
More filters
Journal ArticleDOI

A practical guidance on the use of intravenous insulin infusion for management of inpatient hyperglycemia: Intravenous Insulin Infusion for Management of Inpatient Hyperglycemia.

Alpesh Goyal, +6 more
- 13 Aug 2021 - 
TL;DR: In this article, a practical guidance on the use of intravenous insulin infusion for managing inpatient hyperglycemia is provided based on the review of available literature and personal experience of authors.
Journal Article

Once-weekly glucagon-like peptide 1 receptor agonists.

Sanjay Kalra, +1 more
- 01 Jul 2015 - 
TL;DR: The once-weekly glucagon-like peptide 1 receptor agonists (QW GLP1RA) represent a major advancement in diabetes pharmaco-therapeutics and the clinical placement and posology of these drugs are highlighted.
Journal Article

Choosing injectable therapy: The metabolic fulcrum.

Sanjay Kalra, +1 more
- 01 Jul 2016 - 
TL;DR: This clinical decision making hypothesis utilizes the metabolic fulcrum based approach to classify persons with diabetes into three categories: predominantly catabolic, eubolic, and predominantly [maladaptive] anabolic, which helps define choice of injectable therapy in type 2 diabetes mellitus.
Journal ArticleDOI

What drives glycemic control in a person living with diabetes

Rajiv Singla, +2 more
- 24 Jul 2021 - 
TL;DR: In this paper, the authors delineate factors impacting glycemic control from real-world data and delineate the contribution of patient or care team-dependent factors towards glycemic controlling.
Journal ArticleDOI

Lifestyle InterVention IN Gestational diabetes (LIVING) in India, Bangladesh and Sri Lanka: protocol for process evaluation of a randomised controlled trial.

Janani Shanthosh, +10 more
- 13 Dec 2020 - 
TL;DR: The aim of this process evaluation is to understand what worked, and why, during the LIVING intervention implementation, and to provide additional data that will assist in the interpretation of the LIVES InterVention IN Gestational diabetes Study results.